Back to results
US 2015/0057332 A1Published application
Methods for the Treatment of Nonalcoholic Steatohepatitis
AssigneesInserm (Institut National De La Sante Et De La Recherche Medicale), Universite Paris Descartes
InventorsAlain Tedgui, Xavier Loyer, Pierre-Emmanuel Rautou
Life of this patent
Estimating the term…
Abstract
The present invention relates to the treatment of nonalcoholic steatohepatitis (NASH), in particular to a compound that inhibits miR-21 expression for use in the treatment of nonalcoholic steatohepatitis.
Claims7
1-3. (canceled)
A pharmaceutical composition for the treatment of nonalcoholic steatohepatitis (NASH) in a patient in need thereof comprising a miR-21 inhibitor and a pharmaceutically acceptable carrier.
A method for the treatment of NASH in a patient in need thereof comprising the step of
- administering to said patient a therapeutic amount of a miR-21 inhibitor and a pharmaceutically acceptable carrier.
Dependencies are inferred from the claim text.